This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Jenkinson, S. Articles by Smith, C. D. Search for Related Content PubMed PubMed Citation Articles by Jenkinson, S. Articles by Smith, C. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB BUTYRIC ACID DIMETHYL SULFOXIDE Social Bookmarking                   What's this?

Development of a Novel High-Throughput Surrogate Assay to Measure HIV Envelope/CCR5/CD4-Mediated Viral/Cell Fusion Using BacMam Baculovirus Technology

GlaxoSmithKline Research and Development, Research Triangle Park, NC

David C. Mc Coy

GlaxoSmithKline Research and Development, Research Triangle Park, NC

Sandy A. Kerner

GlaxoSmithKline Research and Development, Research Triangle Park, NC

Robert G. Ferris

GlaxoSmithKline Research and Development, Research Triangle Park, NC

Wendell K. Lawrence

GlaxoSmithKline Research and Development, Research Triangle Park, NC

William C. Clay

GlaxoSmithKline Research and Development, Research Triangle Park, NC

J. Patrick Condreay

GlaxoSmithKline Research and Development, Research Triangle Park, NC

Chari D. Smith

GlaxoSmithKline Research and Development, Research Triangle Park, NC

The initial event by which M-tropic HIV strains gain access to cells is via interaction of the viral envelope protein gp120 with the host cell CCR5 coreceptor and CD4. Inhibition of this event reduces viral fusion and entry into cells in vitro. The authors have employed BacMam baculovirus-mediated gene transduction to develop a cell/cell fusion assay that mimics the HIV viral/cell fusion process and allows high-throughput quantification of this fusion event. The assay design uses human osteosarcoma (HOS) cells stably transfected with cDNAs expressing CCR5, CD4, and long terminal repeat (LTR)-luciferase as the recipient host cell. An HEK-293 cell line transduced with BacMam viral constructs to express the viral proteins gp120, gp41, tat, and rev represents the virus. Interaction of gp120 with CCR5/CD4 results in the fusion of the 2 cells and transfer of tat to the HOS cell cytosol; tat, in turn, binds to the LTR region on the luciferase reporter and activates transcription, resulting in an increase in cellular luciferase activity. In conclusion, the cell/cell fusion assay developed has been demonstrated to be a robust and reproducible high-throughput surrogate assay that can be used to assess the effects of compounds on gp120/CCR5/CD4-mediated viral fusion into host cells.

Key Words: BacMam baculovirus-mediated gene transduction • high-throughput screening • HIV • cell/cell fusion assay • CCR5

Journal of Biomolecular Screening, Vol. 8, No. 4, 463-470 (2003)
DOI: 10.1177/1087057103255747


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Ji, J. Zhang, N. Cammack, and S. Sankuratri Development of a Novel Dual CCR5-Dependent and CXCR4-Dependent Cell-Cell Fusion Assay System with Inducible gp160 Expression J Biomol Screen, February 1, 2006; 11(1): 65 - 74. [Abstract] [PDF]